These Terms of Use constitute a legally binding agreement between you and NeuropathIQ Inc. governing your use of the NeuropathIQ platform and related services. By creating an account or using the service, you agree to these Terms and our Privacy Policy.
NeuropathIQ is an evidence intelligence platform that aggregates, normalizes, and organizes publicly available biomedical literature, clinical trial information, biomedical ontologies, and related scientific datasets into a structured, deterministic evidence architecture. The platform includes an AI-assisted feature called Research Insight, which generates a bounded, evidence-grounded explanation of a specific pattern already identified by the deterministic knowledge graph — for example, why a set of literature-observed genes converges on a given biological pathway. Research Insight is generated only when a researcher explicitly requests it, assists researchers by organizing, summarizing, explaining, or contextualizing evidence already present in the graph, and always preserves links to the underlying scientific sources and ontology provenance it drew on.
The service is provided for research and educational purposes only. It is not a medical device, clinical decision support system, regulatory advisory system, or investment advisory service. Use of NeuropathIQ does not create a physician-patient, consultant, legal, investment, or other professional relationship.
"Evidence Intelligence" refers to NeuropathIQ's analytical layer: source evidence (publicly available biomedical literature and related datasets), normalized into a deterministic knowledge graph through governed ontology, and an assistive interpretation layer — including Research Insight — operating on top of that evidence. NeuropathIQ's primary asset is its structured biomedical knowledge architecture. Artificial intelligence does not create the underlying relationship, determine whether a relationship exists, or become source evidence itself — it only interprets evidence and relationships that already exist in the deterministic graph, and AI-generated interpretations are never written back into the knowledge graph as source fact.
Certain normalization rules, ontologies, and evidence relationships may be refined through expert review as the platform evolves. Such review does not imply validation or endorsement of every platform output.
The service is intended for research scientists, academic researchers, neurologists and clinicians, clinical trial coordinators, pharmaceutical research professionals, and students under supervision of qualified professionals. You must be at least 18 years of age.
NeuropathIQ's current Platform does not require a paid account or subscription to use. If account-based or paid services are introduced in the future, separate terms will apply to those services before they launch.
You may use the service to search and browse neuroscience research data, explore structured evidence connections across neurological diseases, biomarkers, pathways, genes, drugs, and clinical trials for research planning purposes, share insights with colleagues in a research context, and export and cite data with appropriate attribution.
You may NOT use the service to:
You acknowledge that AI-assisted analyses are hypothesis-generating only and require independent verification against original scientific literature; Evidence Intelligence outputs may contain errors or inaccuracies; relationships in the knowledge graph are established deterministically from structured evidence, not generated or predicted by AI; AI-assisted explanations represent an interpretation of that evidence and may not reflect current expert consensus; and NeuropathIQ does not warrant the accuracy, completeness, or fitness for any particular purpose of any AI-assisted analysis.
Research Insight specifically: it is derived analysis, not source evidence; it does not establish causation between a disease and a biological pathway or process; and it does not constitute medical advice, diagnosis, treatment advice, or clinical decision support. Before relying on any Research Insight output, you must independently review the underlying cited literature and ontology provenance it references.
When citing information obtained through NeuropathIQ in academic publications, you must attribute the original data source (e.g., "data from PubMed/NCBI," "trial data from ClinicalTrials.gov"). NeuropathIQ's AI-assisted analyses should be attributed to "NeuropathIQ AI-assisted analysis [date accessed]" with a note that content is AI-assisted and hypothesis-generating only.
NeuropathIQ aggregates third-party public scientific data and does not guarantee the completeness, availability, or continued accuracy of those external sources. NeuropathIQ's analysis does not represent the views of PubMed/NCBI, ClinicalTrials.gov, NIH, FDA, trial sponsors, or any other data source.
NeuropathIQ displays titles, authors, abstracts (where permitted), DOIs, and links to original sources. We do not reproduce copyrighted full-text journal articles. AI-assisted analyses represent computational interpretations of publicly available scientific information and do not replace or supersede the original scientific publications. They are not reproductions of publisher-owned content.
Trial outcome descriptions use factual language only (e.g., "met primary endpoint" / "did not meet primary endpoint") and cite source trial reports. We do not make editorial judgments about trial sponsors or their products.
The NeuropathIQ platform, including its algorithms, knowledge graph structure, taxonomy, normalization methodology, and AI-assisted analysis framework, is owned by NeuropathIQ Inc. and protected by Canadian copyright law, trade secret law, and applicable international IP laws. The underlying scientific data is sourced from public domain sources subject to those sources' respective terms.
In addition to the prohibited uses in Section 6, you may not engage in: model extraction or prompt harvesting; automated benchmarking of NeuropathIQ AI systems; dataset reconstruction or knowledge graph copying; reverse engineering of normalization methods or entity resolution logic; or any systematic effort to replicate the NeuropathIQ evidence architecture.
NeuropathIQ is intended for scientific research, literature exploration, education, and hypothesis generation by researchers, scientific and biomedical professionals, and appropriate educational users. It is not intended for clinical decision-making, diagnostic use, treatment planning, regulatory submissions, or investment purposes.
Scientific knowledge evolves continuously. NeuropathIQ does not warrant that publications, biomarker interpretations, pathway models, ontology relationships, or AI-assisted analyses are complete, current, or error-free. Users are responsible for independently verifying all information against primary scientific literature before relying on it for any purpose.
Use of NeuropathIQ does not create a physician-patient, researcher-institution, consultant, legal, investment, or any other professional relationship between you and NeuropathIQ Inc. or any of its personnel.
NeuropathIQ's current Platform does not charge subscription fees or process payments. Applicable payment terms will be provided before any paid services are introduced.
NeuropathIQ's current Platform does not require an account, so there is nothing to terminate. If account-based services are introduced in the future, this section will be updated to describe applicable termination and data-retention terms before those services launch.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, NEUROPATHIQ SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES. IN NO EVENT SHALL NEUROPATHIQ'S TOTAL LIABILITY EXCEED THE AMOUNT YOU PAID IN THE 12 MONTHS PRECEDING THE CLAIM (WHICH, UNDER THE CURRENT FREE-TO-USE V1 PLATFORM, IS $0).
NEUROPATHIQ IS NOT LIABLE FOR ANY CLINICAL, RESEARCH, INVESTMENT, OR BUSINESS DECISIONS MADE IN RELIANCE ON RESEARCH INSIGHT OR OTHER AI-ASSISTED ANALYSIS FROM THE PLATFORM.
You agree to indemnify NeuropathIQ and its officers, directors, and employees from and against any claims, liabilities, and expenses arising from your use of the service or violation of these Terms.
These Terms are governed by the laws of British Columbia and the federal laws of Canada. Disputes shall be submitted to the courts of British Columbia, Canada.
We will notify you of material changes by email and platform notice at least 30 days before changes take effect. Continued use constitutes acceptance.
Questions about these Terms: legal@neuropathiq.com
NeuropathIQ Inc. · British Columbia, Canada